ClearPoint Neuro Reports Third-Quarter 2026 Results
Revenue rose 36% to $12.1 million from $8.9 million a year earlier. Net loss widened to $7.5 million from $5.9 million, and diluted loss per share was $(0.24) versus $(0.21).
ClearPoint Neuro reported third-quarter 2026 revenue of $12.1 million, up 36% from $8.9 million a year earlier, while its net loss widened to $7.5 million from $5.9 million. Diluted loss per share was $(0.24), compared with $(0.21) in the prior-year quarter.Financial HighlightsBusiness HighlightsOr…